Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States

By sjmartinez • March 18, 2025

Sisk BA, Eng W, Aye J, Mack J, Tran A, Ogino J, Pearson E, Bies J, Smink G, Shah SD, Mohney L, Fassel H, Schulte R, Chang VY, Tessem RA, Hogeling M, Swaminathan N, McLean TW, Blatt J, Alturky S, Wu M, Atkinson A, Al-Huniti A, Massey G, Engel E, Ricci K, Echols T, Kumar S, Fox M, King KA. Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States. Pediatr Blood Cancer. 2025 Mar 17:e31661. doi: 10.1002/pbc.31661. Epub ahead of print. PMID: 40091541.

Tags: Dermatology, DGSOM Student, disparities, Publications, sociodemographics, vascular malformation

Single-cell and spatial profiling reveal cDC2A-CXCL13+CD8+ T-epithelial cell crosstalk and cytotoxicity through TNFRSF9 in cutaneous and mucosal lichen planus

Jiang R, Bogle R, Xing X, Kirma J, Fox J, Harms PW, Do T, Billi AC, Kahlenberg JM, Modlin RL, Teles R, West J, Mangold[...]

Concordance Between Patient- and Physician-Reported Improvement With Dupilumab in Atopic Dermatitis

Conde G, Carmenate Y, Bello G, Armstrong AW. Concordance Between Patient- and Physician-Reported Improvement With Dupilumab in Atopic Dermatitis. J Dermatol. 2026 Mar 13. doi:[...]

Lebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitis

Silverberg JI, Bieber T, Eyerich K, Armstrong AW, Nickoloff BJ, Natalie CR, Gallo G, Okragly A, Wolf E, Xu C, Moser BA, Rueda MJ, Elmaraghy[...]